Sección para completar los datos relacionados con las publicaciones que sirven de base al protocolo. Refiera hasta un máximo de 10 referencias.
Referencias:
1. Saad F, Chi KN, Finelli A, Hotte SJ, Izawa J, Kapoor A, et al. The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC). Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2015;9(3-4):90-6.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians. 2015;65(1):5-29.
3. MINSAP. Anuario Estadístico de Salud 2016. . 2017.
4. 1Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JY, Chen CX, et al. Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(17):6686-91.
5. Klezovitch O, Risk M, Coleman I, Lucas JM, Null M, True LD, et al. A causal role for ERG in neoplastic transformation of prostate epithelium. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(6):2105-10.
6. NCCN. Guidelines Prostate Cancer Version 3. .2016.
7. Gillessen S, Attard G, Beer TM, Beltran H, Bossi A, Bristow R, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. European urology. 2018;73(2):178-211.
8. Rodriguez PC, Popa X, Martinez O, Mendoza S, Santiesteban E, Crespo T, et al. A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(15):3782-90.
9. Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, et al. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(12):1402-18.
10. Srigley JR DB, Egevad L, Samaratunga H, Yaxley J, Evans AJ. . One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason grading. . Canadian Urological Association Journal 2016;10((9-10)):339-41.